Fibrillation atriale

Vendredi 18 Janvier 2019   16:00-17:30   Salle 342 B
JESFC 2019   |   Communications libres
16:00 • Michel Galinier
The efficacy and safety of apixaban versus warfarin are preserved in patients with atrial fibrillation and extreme body weight: insights from the ARISTOTLE study
Voir la présentation
Safety and efficacy of left atrial appendage closure in routine practice in France: results of the French Nationwide Left Atrial Appendage Closure Registry
Voir la présentation
16:30 • Michel Galinier
Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients: the dose subgroup analysis of the ARISTOPHANES study
Voir la présentation
16:45 • Luc Lorgis
Safety and efficacy of left atrial appendage occlusion guided by CT-scan and intracardiac echocardiography from the Left atrium.
Voir la présentation
17:00 • Thibaut Pommier
Left atrial remodeling and brain natriuretic peptide levels variation after left atrial appendage occlusion.
Voir la présentation
17:15 • Fabien Picard
Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: a dose subgroup analysis of the ARISTOPHANES study
Voir la présentation